Patent Cliff Defense

Navigate the Largest Patent Cliff in Pharmaceutical History

Over $200B in branded revenue faces patent expiration between 2025-2030. Our decision intelligence platform compresses years of strategic planning into weeks of decisive action.

$0B+Specific Revenue at Risk
0Major Companies Affected
0 mo → 6 wkPlanning Acceleration
0%Cost Reduction

Lifecycle Stages We Address

Our patent cliff intelligence covers the critical late-lifecycle stages where franchise defense and transition decisions are made.

Discovery

Target identification and validation

Preclinical

IND-enabling studies

Phase 1

Safety and dosing

Phase 2

Efficacy signals

Phase 3

Pivotal trials

Filing

NDA/BLA submission

Launch

Market entry

Growth

Indication expansion

Peak

Maximum revenue

Defend

Lifecycle extension and patent defense strategies

Harvest

Optimize remaining commercial value

LOE & Beyond

Biosimilar defense and franchise transition

War-Gaming Simulations in Action

See how our platform models biosimilar entry scenarios, pricing erosion curves, and franchise transition strategies in real-time.

How It Works

Decision Intelligence Workflow

From data ingestion through strategic recommendation, our platform delivers actionable intelligence at every step.

IngestModelSimulatePrioritizeData Sourc...Data SourcesAI Synthes...AI SynthesisWar-GamingWar-GamingScenariosScenariosRecommenda...Recommendations

Don't wait for the cliff to arrive

Deploy patent cliff intelligence in 4-6 weeks. War-game your franchise transition strategy before competitors establish positioning.